Supplemental

Interest Paid

AbbVie Interest Paid remained flat by 0.0% to $750.50M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 6.8%, from $702.75M to $750.50M. Over 4 years (FY 2021 to FY 2025), Interest Paid shows an upward trend with a 2.6% CAGR. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementCash Flow Statement
SectionSupplemental
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2013
Last reportedQ4 2025Feb 20, 2026

How to read this metric

Increasing interest payments relative to debt levels may signal rising interest rates or a higher cost of borrowing.

Detailed definition

The total cash outflow for interest payments on debt obligations during the period. This metric highlights the cash cost...

Peer comparison

Used to compare the cost of debt and interest coverage ratios against industry peers.

Metric ID: interest_paid

Historical Data

5 years
 FY'21FY'22FY'23FY'24FY'25
Value$2.71B$2.55B$2.47B$2.81B$3.00B
YoY Change-6.1%-3.0%+13.9%+6.8%
Range$2.47B$3.00B
CAGR+2.6%
Avg YoY Growth+2.9%
Median YoY Growth+1.9%
Current Streak2 years growth

Frequently Asked Questions

What is AbbVie's interest paid?
AbbVie (ABBV) reported interest paid of $750.50M in Q4 2025.
How has AbbVie's interest paid changed year-over-year?
AbbVie's interest paid increased by 6.8% year-over-year, from $702.75M to $750.50M.
What is the long-term trend for AbbVie's interest paid?
Over 4 years (2021 to 2025), AbbVie's interest paid has grown at a 2.6% compound annual growth rate (CAGR), from $2.71B to $3.00B.
What does interest paid mean?
The total cash paid for interest on debt.